Efficacy of yogurt drink with added plant stanol esters (Benecol®, Colanta) in reducing total and LDL cholesterol in subjects with moderate hypercholesterolemia: a randomized placebo-controlled crossover trial NCT01461798

Elsa M Vásquez-Trespalacios, Johanna Romero-Palacio, Elsa M Vásquez-Trespalacios, Johanna Romero-Palacio

Abstract

Background: Cardiovascular diseases have become the leading cause of death from chronic diseases in the world. Main risk factors include hypercholesterolemia, which is caused in most cases by a high saturated fat diet. Plant stanol esters partly block cholesterol absorption in the digestive tract and thereby reduce total cholesterol and low-density lipoprotein (LDL) cholesterol serum levels. Based on epidemiological data, a 10 percent reduction of LDL cholesterol leads to a 20 percent decrease in the coronary heart disease risk throughout life. The aim of this study was to evaluate the efficacy of yogurt drink with added plant stanol esters (Benecol® yogurt drink) in higher doses than the typically used (2g/d stanols), in lowering blood lipids in moderately hypercholesterolemic subjects.

Methods: A randomized double-blind crossover, placebo-controlled study in moderately hypercholesterolemic subjects (n = 40) aged between 20 and 50 years old.

Results: Yogurt drink with added plant stanols (4 g) as esters (Benecol®, Colanta) consumption compared to regular yogurt drink caused a statistically significant decrease in total cholesterol and low density lipoprotein cholesterol by 7.2% and 10.3%. During the two periods and compared to controls, high-density lipoprotein cholesterol and triglycerides were not significantly different.

Conclusions: Yogurt drink with an active ingredient in Benecol®, plant stanol esters, reduced total cholesterol and LDL cholesterol in moderately hypercholesterolemic subjects.

Trial registration: NCT01461798.

Figures

Figure 1
Figure 1
Difference between plant stanol ester and placebo treatments for serum lipids (% change from first-period baseline).
Figure 2
Figure 2
Intervention scheme.

References

    1. Harland JI. Food combinations for cholesterol lowering. Nutr Res Rev. 2012;25(2):249–266. doi: 10.1017/S0954422412000170.
    1. Katan MB, Boekschoten MV, Connor WE, Mensink RP, Seidell J, Vessby B, Willett W. Which are the greatest recent discoveries and the greatest future challenges in nutrition? Eur J Clin Nutr. 2009;63(1):2–10. doi: 10.1038/sj.ejcn.1602923.
    1. Law M. Plant sterol and stanol margarines and health. BMJ. 2000;320(7238):861–864. doi: 10.1136/bmj.320.7238.861.
    1. Ling WH, Jones PJ. Dietary phytosterols: a review of metabolism, benefits and side effects. Life Sci. 1995;57(3):195–206. doi: 10.1016/0024-3205(95)00263-6.
    1. Rocha M, Banuls C, Bellod L, Jover A, Victor VM, Hernandez-Mijares A. A review on the role of phytosterols: new insights into cardiovascular risk. Curr Pharm Des. 2011;17(36):4061–4075. doi: 10.2174/138161211798764852.
    1. Jones PJ, Raeini-Sarjaz M, Ntanios FY, Vanstone CA, Feng JY, Parsons WE. Modulation of plasma lipid levels and cholesterol kinetics by phytosterol versus phytostanol esters. J Lipid Res. 2000;41(5):697–705.
    1. de Jong A, Plat J, Mensink RP. Metabolic effects of plant sterols and stanols (Review) J Nutr Biochem. 2003;14(7):362–369. doi: 10.1016/S0955-2863(03)00002-0.
    1. Ikeda I, Sugano M. Comparison of absorption and metabolism of beta-sitosterol and beta-sitostanol in rats. Atherosclerosis. 1978;30(3):227–237. doi: 10.1016/0021-9150(78)90049-7.
    1. Ikeda I, Tanaka K, Sugano M, Vahouny GV, Gallo LL. Inhibition of cholesterol absorption in rats by plant sterols. J Lipid Res. 1988;29(12):1573–1582.
    1. De Smet E, Mensink RP, Plat J. Effects of plant sterols and stanols on intestinal cholesterol metabolism: suggested mechanisms from past to present. Mol Nutr Food Res. 2012;56(7):1058–1072. doi: 10.1002/mnfr.201100722.
    1. Heinemann T, Kullak-Ublick GA, Pietruck B, von Bergmann K. Mechanisms of action of plant sterols on inhibition of cholesterol absorption. Comparison of sitosterol and sitostanol. Eur J Clin Pharmacol. 1991;40(Suppl 1):S59–S63. doi: 10.1007/BF03216292.
    1. Grundy SM. United States Cholesterol Guidelines 2001: expanded scope of intensive low-density lipoprotein-lowering therapy. Am J Cardiol. 2001;88(7B):23J–27J. doi: 10.1016/S0002-9149(01)01931-2.
    1. Lees AM, Mok HY, Lees RS, McCluskey MA, Grundy SM. Plant sterols as cholesterol-lowering agents: clinical trials in patients with hypercholesterolemia and studies of sterol balance. Atherosclerosis. 1977;28(3):325–338. doi: 10.1016/0021-9150(77)90180-0.
    1. Miettinen TA, Puska P, Gylling H, Vanhanen H, Vartiainen E. Reduction of serum cholesterol with sitostanol-ester margarine in a mildly hypercholesterolemic population. N Engl J Med. 1995;333(20):1308–1312. doi: 10.1056/NEJM199511163332002.
    1. Moghadasian MH, Frohlich JJ. Effects of dietary phytosterols on cholesterol metabolism and atherosclerosis: clinical and experimental evidence. Am J Med. 1999;107(6):588–594. doi: 10.1016/S0002-9343(99)00285-5.
    1. Williams CL, Bollella MC, Strobino BA, Boccia L, Campanaro L. Plant stanol ester and bran fiber in childhood: effects on lipids, stool weight and stool frequency in preschool children. J Am Coll Nutr. 1999;18(6):572–581. doi: 10.1080/07315724.1999.10718891.
    1. Demonty I, Ras RT, van der Knaap HC, Duchateau GS, Meijer L, Zock PL, Geleijnse JM, Trautwein EA. Continuous dose-response relationship of the LDL-cholesterol-lowering effect of phytosterol intake. J Nutr. 2009;139(2):271–284. doi: 10.3945/jn.108.095125.
    1. LaRosa JC. Low-density lipoprotein cholesterol reduction: the end is more important than the means. Am J Cardiol. 2007;100(2):240–242. doi: 10.1016/j.amjcard.2007.02.089.
    1. Laitinen K, Gylling H. Dose-dependent LDL-cholesterol lowering effect by plant stanol ester consumption: clinical evidence. Lipids Health Dis. 2012;11:140. doi: 10.1186/1476-511X-11-140.
    1. Musa-Veloso KPT, Elliot JA, Chung C. A comparison of the LDL-cholesterol lowering efficacy of plant stanols and plant sterols over a continuous dose range: results of a meta-analysis of randomized, placebo-controlled trials. Prostaglandins Leukot Essent Fatty Acids. 2011;85:9–28. doi: 10.1016/j.plefa.2011.02.001.
    1. EFSA panel on Dietetic Products NaA Scientific opinion on the substantiation of a heath claim related to 3g/day plant stanols as plant stanol esters and lowering blood LDL-Cholesterol and reduced risk of (coronary) heart disease pursuant to Article 14 of Regulation (EC) No 1924/20061. EFSA J. 2012;10(5):1–17.
    1. Biological variation database and quality specifications for imprecision, bias and total error (desirable and mínimum) The 2014 update [Internet]. 2014 [cited 26/01/2014]. Available from:
    1. Noakes M, Clifton PM, Doornbos AM, Trautwein EA. Plant sterol ester-enriched milk and yoghurt effectively reduce serum cholesterol in modestly hypercholesterolemic subjects. Eur J Nutr. 2005;44(4):214–222. doi: 10.1007/s00394-004-0513-z.
    1. Mensink RP, Ebbing S, Lindhout M, Plat J, van Heugten MM. Effects of plant stanol esters supplied in low-fat yoghurt on serum lipids and lipoproteins, non-cholesterol sterols and fat soluble antioxidant concentrations. Atherosclerosis. 2002;160(1):205–213. doi: 10.1016/S0021-9150(01)00562-7.
    1. Seppo L, Jauhiainen T, Nevala R, Poussa T, Korpela R. Plant stanol esters in low-fat milk products lower serum total and LDL cholesterol. Eur J Nutr. 2007;46(2):111–117. doi: 10.1007/s00394-006-0639-2.
    1. Miettinen TA, Vuoristo M, Nissinen M, Jarvinen HJ, Gylling H. Serum, biliary, and fecal cholesterol and plant sterols in colectomized patients before and during consumption of stanol ester margarine. Am J Clin Nutr. 2000;71(5):1095–1102.
    1. E R. Dual Cholesterol Inhibition Roles of Intestinal and Hepatic Regulation. Rev Esp Cardiol. 2006;6:52–62. doi: 10.1157/13091599.
    1. Sanders DJ, Minter HJ, Howes D, Hepburn PA. The safety evaluation of phytosterol esters. Part 6. The comparative absorption and tissue distribution of phytosterols in the rat. Food Chem Toxicol. 2000;38(6):485–491. doi: 10.1016/S0278-6915(00)00021-1.
    1. Keszthelyi D, Knol D, Troost FJ, van Avesaat M, Foltz M, Masclee AA. Time of ingestion relative to meal intake determines gastrointestinal responses to a plant sterol-containing yoghurt drink. Eur J Nutr. 2013;52(4):1417–1420. doi: 10.1007/s00394-012-0440-3.
    1. Algorta Pineda J, Chinchetru Ranedo MJ, Aguirre Anda J, Francisco Terreros S. Hypocholesteremic effectiveness of a yogurt containing plant stanol esters. Rev Clin Esp. 2005;205(2):63–66. doi: 10.1157/13072497.
    1. Kriengsinyos W, Sumriddetchkajorn K, Yamborisut U. Reduction of LDL-cholesterol in mildly hypercholesterolemic Thais with plant stanol ester-fortified soy milk. Journal of the Medical Association of Thailand. Chotmaihet Thangphaet. 2011;94(11):1327–1336.
    1. Katan MB, Grundy SM, Jones P, Law M, Miettinen T, Paoletti R, Stresa Workshop Participants Efficacy and safety of plant stanols and sterols in the management of blood cholesterol levels. Mayo Clin Proc. 2003;78(8):965–978. doi: 10.1016/S0025-6196(11)63144-3.
    1. Theuwissen E, Plat J, van der Kallen CJ, van Greevenbroek MM, Mensink RP. Plant stanol supplementation decreases serum triacylglycerols in subjects with overt hypertriglyceridemia. Lipids. 2009;44(12):1131–1140. doi: 10.1007/s11745-009-3367-6.
    1. Escurriol V, Cofán M, Moreno Iribas MC, Larrañaga N, Sánchez MJ, Navarro C, Quirós JR, González CA, Corella D, Ros E. Plasma phytosterols: markers of a healthy diet and a lower cardiometabolic risk in the spanish epic population study. Clin Invest Arterioscl. 2009;21(3):106–114.
    1. Escola-Gil JC, Quesada H, Julve J, Martin-Campos JM, Cedo L, Blanco-Vaca F. Sitosterolemia: diagnosis, investigation, and management. Curr Atheroscler Rep. 2014;16(7):424. doi: 10.1007/s11883-014-0424-2.

Source: PubMed

스폰서 및 공동 작업자

건강 상태

약물 개입

3
구독하다